October 24th
7.00 PM - 8.30 PM CET
Novotel Campo de las Naciones • Madrid, Spain
IN-PERSON ONLY · No live-stream available
WHERE AI MEETS CLINICAL DECISIONS
MEDTalk is an interactive scientific discussion forum that brings together leading oncology experts to exchange insights, debate emerging evidence, and explore advances shaping the future of cancer research and care.
This year, MEDTalk will explore how artificial intelligence is reshaping the way oncology research is designed, conducted, and translated into clinical practice.
Leading experts will examine where AI can deliver meaningful value, from clinical trial design and real-world data analysis to treatment decision-making and outcome prediction, while addressing the ethical, regulatory, and implementation challenges that will shape its responsible adoption.
Join us to explore the opportunities, challenges, and next steps defining the future of AI in oncology.
AGENDA
7:00 PM - 8:30 PM
-
Welcome & Introduction
-
AI for Faster, Smarter Oncology Trials
Dr Enrique Grande + Discussion
-
AI, Real-World Data & Evidence
Dr Miriam Koopman + Discussion
-
AI for Clinical Decision Making & Biomarkers
Dr Loic Verlingue + Discussion
-
AI: Ethics, Disparities & Equity
Dr Jonathan Lim + Discussion
-
Q&A and Closing
SPEAKERS
.png)
WHAT TO EXPECT?
You will gain practical insights into how AI is transforming real-world oncology
-
Understand how AI is reshaping clinical decision-making in oncology
-
Hear directly from leading European experts at the forefront of innovation
-
Explore real-world applications, data, and case-driven insights
-
Address key challenges including ethics, bias, and implementation
-
Connect with peers across oncology, research, and innovation
LOCATION
Sponsors
This event is supported by industry partners committed to advancing oncology innovation.
About MEDSIR
A new model for collaborative research in clinical oncology
MEDSIR has more than a decade of experience developing strategic clinical trials in oncology, by combining the medical knowledge of our KOLs network, with a multidisciplinary expertise in clinical trials. Our innovative strategies lead to the generation of groundbreaking collaborative trials that respond to unmet clinical need while complementing the internal development program of your drug.
"
WE WANT TO IMPROVE THE LIVES OF CANCER PATIENTS BY ENSURING THEY HAVE ACCESS TO THE BEST TREATMENT OPTIONS FOR THEIR DISEASE.
